pharmaphorum7d
Novartis and GSK’s multi-billion dollar swaps to transform both companies
The four-pronged strategy begins with the acquisition of GSK's oncology portfolio ... health division to Lilly for $5.4 billion reflects major changes in the animal health market, sparked by ...
Fierce Pharma3d
GSK, Novartis, Lilly among Big Pharmas celebrating International Women’s Day 2025
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
Yahoo Finance9d
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
No major differences ... and discounted brand-name drugs. The report provides estimated price thresholds that CMS should ...
Fierce Biotech10d
GSK gears up for depemokimab debut with twin FDA filings and phase 3 data dump
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...
Business Insider India6y
A top executive at GSK reveals why it's prepared to ditch the brands that helped turn it into a $95 billion powerhouse
having the business as part of GSK gave it more stability, letting the pharma side of the business take more risks. Read more: Two huge drugmakers are spinning off iconic brands like Advil ...
Warc2y
Pain relief: How GSK is using semiotics to take the headache out of brand strategy
GSK has drawn on a vast bank of images and conversations from ... In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with ...